CI

At a glance

ClinicalIndex Comparison Record
Phase 4Completed· 216 enrolled
Drug / intervention
Duloxetinedrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00322621
NCT00322621Phase 4Completed
CompareCT.gov

Maintenance of Effect of Duloxetine 60 mg Once Daily in Patients With Diabetic Peripheral Neuropathic Pain

Eli Lilly and Company·interventional·Posted May 8, 2006·Updated Feb 7, 2011

In Brief

A Phase 4 clinical trial evaluating Duloxetine for Diabetic Neuropathies. Completed, enrolled 216 participants across 19 sites in 4 countries.

Detailed Summary

To determine if duloxetine 60 mg once daily can work up to 6 months in treating pain from Diabetic Neuropathy.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsDiabetic Neuropathies
CountriesBrazil, France, Germany, Italy
CollaboratorsBoehringer Ingelheim

Timeline

Phase 4CompletedFinished
2006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedMay 8, 2006
Enrollment StartApr 1, 2006
Primary CompletionOct 1, 2007
TodayJul 2, 2026
Enrollment to primary: 1.5 yearsPosted 20.2 years ago

Interventions

Duloxetinedrug